Skip to content

Public FDA record

Z-0928-2023: BD Pyxis MedBank System - Product Label/labeling pending

Recall record Z-0928-2023 for CareFusion 303, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0928-2023
Company in FDA record
CareFusion 303, Inc.
FDA classification date
Jan 10, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to customer complaints related to the MedBank software which may indicate that a different medication is loaded in a cubie (drawer) pocket than what is physically loaded and listed on the pocket label. As a result of this issue, a patient could receive the wrong medication or wrong dose of medication that could lead to patient harm.

Source facts

Action
On 12/12/2022, the firm sent an "Urgent: Medical Device Correction" Letter via FedEx 2-Day mail to customers informing them of a software anomaly affecting BD Pyxis MedBank Cabinets with software version v.2.2 or prior. The firm was made aware that when using an atypical workflow the software would indicate that a different medication is loaded in a CUBIE pocket that what is physically loaded and listed on the CUBIE pocket label. This issue may occur when a new CUBIE is placed into an empty position that the software considers already occupied. Customer are instructed to: To mitigate and avoid this issue, only restock or destock CUBIE pockets when in the Restock / Destock workflow. If a CUBIE is removed atypically, and you do not have the privileges to activate the Restock/Destock workflow, call BD Support to assist with inserting the CUBIE correctly into the MedBank automated dispensing cabinet. Do not manually insert the CUBIE without support. Actions to be taken by Pharmacy: 1. Provide a copy of this customer letter to all facilities within their distribution network that have the affected products. 2. Promptly complete and return the enclosed Customer Response Form to acknowledge receipt of this notification and that they understand the information provided in this letter. Actions to be taken by the Customer: 1. Post this Customer Notification on all affected devices until additional software updates have been released. 2. Promptly complete and return the enclosed Customer Response Form to acknowledge receipt of this notification and that you understand the information provided in this letter. 3. If customers experience a memory overwrite issue, reach out to BD Technical Support/Product Complaints at 1-866-930-9251. Actions to be taken by BD: 1. A software update to version 2.3.1.8 is currently in progress and will be available to all affected customers by December 2022. BD will contact customers to schedule a convenient time to update the software. BD will re
Initiated
2022-12-12
Root cause
Software design
Distribution
U.S. Nationwide distribution including in the states of AK, AL, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, WA, WI, and WV.
Recall number
Z-0928-2023
Recall status
Open, Classified
CDRH record ID
196727
FDA classified
2023-01-10
Recall event number
91099

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗